From a clinical perspective, our results demonstrated that NAMPT levels were elevated in the circulating sEV of HCC patients compared to those in control individuals and patients with hepatitis B virus (HBV) infection and cirrhosis. Here, NAMPT is linked to hepatocellular carcinoma.